Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01478
Species: Homo sapiens
Position : chr6:32595564-32596093
Year: 2020
Title: A super enhancer controls expression and chromatin architecture within the MHC class II locus.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: Burkitt lymphoma
PMID:  31753848
MONDO: MONDO:0007243
Tissue: blood
Tissue Ontology ID: UBERON:0000178
Cell Source: Raji
CVCL ID: CVCL_0511
Cell Type: B lymphocyte
Experiment Type: TF binding assay; chromatin interaction assay
High Throughput Method: CTCF ChIP-seq; H3K27ac ChIP-seq
Low Throughput Method: ChIP-qPCR; 3C; CRISPR-Cas9 XL9-region deletion; CRISPR-Cas9
About Target Gene
Target gene : HLA-DQA1
About TF
TF name : CTCF
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
CTCF Activation of anterior HOX genes in hindbrain development during early embryogenesis reactome 120
CTCF TGF_beta_Receptor netpath 220
Enhancer Associated Network
Overlapping Enhancers (hg19)
No overlapping enhancers found in hg19 at this locus.
Expression of Target Genes for the Enhancer